Antiviral Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.3 | Q1 | 86.4% | 1.353 | Q1 | 90.3% |
| 2024 | 4.0 | Q1 | 78.6% | 1.195 | Q1 | 88.3% |
| 2023 | 4.5 | Q1 | 80.5% | 1.500 | Q1 | 92.7% |
| 2022 | 7.6 | Q1 | 87.5% | 1.701 | Q1 | 94.4% |
| 2021 | 10.1 | Q1 | 86.8% | 2.213 | Q1 | 96.6% |
| 2020 | — | — | 2.052 | Q1 | 95.8% | |
| 2019 | — | — | 1.596 | Q1 | 93.4% | |
| 2018 | — | — | 1.656 | Q1 | 93.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1872-9096
ISSN
0166-3542
country
NLcoverage
1959, 1981-2026